APA (7th ed.) Citation

Amrein, P. C., Attar, E. C., Takvorian, T., Hochberg, E., Ballen, K. K., Leahy, K. M., . . . Brown, J. R. (2010). Response to Dasatinib In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Correlates with p-Lyn and p-Syk. Blood, 116(21), 2457. https://doi.org/10.1182/blood.V116.21.2457.2457

Chicago Style (17th ed.) Citation

Amrein, Philip C., et al. "Response to Dasatinib In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Correlates with P-Lyn and P-Syk." Blood 116, no. 21 (2010): 2457. https://doi.org/10.1182/blood.V116.21.2457.2457.

MLA (9th ed.) Citation

Amrein, Philip C., et al. "Response to Dasatinib In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Correlates with P-Lyn and P-Syk." Blood, vol. 116, no. 21, 2010, p. 2457, https://doi.org/10.1182/blood.V116.21.2457.2457.